|
To simplify the process for obtaining 340B drugs and
to make it more efficient, the original 340B legislation
contained a special requirement that mandated the
establishment of a "prime vendor." A prime
vendor is typically a single "preferred"
wholesaler that specializes in serving a group of
customers - here covered entities in the 340B Program.
Benefits of the 340B Prime Vendor Program include:
- Familiarity with subtleties of the
Section 340B program
- Value-added services
- Sub-340B prices, due to negotiations
with drug manufacturers using the collective purchasing
volume and market share potential of covered entities.
As
a result, the 340B Prime Vendor is able to provide
high quality services and low drug prices for the
benefit of the covered entities and their patients.
The 340B Prime Vendor Program (PVP) is
managed by Apexus through a contract awarded by Health
Resources and Services Administration (HRSA), the
federal government branch responsible for
administering the 340B Drug Pricing Program.
Apexus is responsible for the
negotiation of pharmaceutical pricing below the 340B
price as well as improving access to affordable
medications by establishing a distribution network for
pharmaceuticals to covered entities.
There are no costs or risks to joining
the Prime Vendor Program. The Program is funded
through nominal fees charged to distributors and
suppliers to avoid any costs to the covered entity.
For
more information, visit the
340B Prime Vendor
Program website.
|
